Asarina Pharma

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Trump Appointee Ferguson Keeps Biden-E

The directors of Asarina Pharma have finally found a buyer for the Tourette’s syndrome treatment sepranolone after securing a bittersweet deal with US firm Relmada Therapeutics which comes four months

The news that Asarina Pharma is going into liquidation is a disappointment both to the Swedish biotech's shareholders and to Tourette's syndrome patients hoping for safer and more effective therapie

Tourette's syndrome has proved a tough nut to crack pharmacologically but a couple of biotechs – Sweden's Asarina Pharma and Emalex Biosciences Inc. in the US – are advancing promising candidates